Clinical Trial

Feasibility Study of an Accommodating IOL Design

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-04 -> 2027-07 2026-05-20
minor Completion pushed: 2027-11 -> 2028-01 2026-05-20
Trial Details
NCT Number NCT07147192
Lead Sponsor Alcon Research
Conditions Aphakia
Enrollment 85 participants
Start Date 2025-12-03
Primary Completion 2027-07 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-19